Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Rodgers

Showing results (1-10 of 354) with videos related to

Pageof 36
Sort By:
BMJ (Clinical Research Ed.)|June 28, 2003
A cure for cardiovascular disease? Combination treatment has enormous potential, especially in developing countriesAnthony Rodgers
BMJ (Clinical Research Ed.)|August 10, 2023
The polypill and medicines access: two decades and countingAnthony Rodgers, Richard Smith
BMJ (Clinical Research Ed.)|October 22, 2008
Why is there more heat than light concerning the polypill?Anthony Rodgers, Anushka Patel
Hypertension (Dallas, Tex. : 1979)|July 27, 2016
Accumulating Evidence of Benefits From Intensive Blood Pressure Lowering: Are We There Yet?Anthony Rodgers, Abdul Salam
Expert Opinion on Drug Delivery|November 13, 2015
Polypill treatments for cardiovascular diseasesRuth Webster, Anthony Rodgers
Journal of Hypertension|April 4, 2018
False reassurance about the consequences of withdrawing antihypertensive drug therapyAbdul Salam, Anthony Rodgers
Lancet (London, England)|November 11, 2008
Can we eliminate inequalities in coronary disease? AbsolutelyMartin Tobias, Anthony Rodgers
The New England Journal of Medicine|June 14, 2016
A Randomized Trial of Intensive versus Standard Blood-Pressure ControlAnthony Rodgers, Vlado Perkovic
Journal of Clinical Hypertension (Greenwich, Conn.)|March 26, 2019
Cardiovascular events with blood pressure lowering in patients with diabetes and systolic blood pressure below 140 mm HgAbdul Salam, Anthony Rodgers
Lancet (London, England)|October 16, 2023
The ESH guidelines and missed prevention opportunitiesRod Jackson, Anthony Rodgers
Pageof 36

Showing results (1-10 of 354) with videos related to

Sort By:
Pageof 36
BMJ (Clinical Research Ed.)|June 28, 2003
A cure for cardiovascular disease? Combination treatment has enormous potential, especially in developing countriesAnthony Rodgers
BMJ (Clinical Research Ed.)|August 10, 2023
The polypill and medicines access: two decades and countingAnthony Rodgers, Richard Smith
BMJ (Clinical Research Ed.)|October 22, 2008
Why is there more heat than light concerning the polypill?Anthony Rodgers, Anushka Patel
Hypertension (Dallas, Tex. : 1979)|July 27, 2016
Accumulating Evidence of Benefits From Intensive Blood Pressure Lowering: Are We There Yet?Anthony Rodgers, Abdul Salam
Expert Opinion on Drug Delivery|November 13, 2015
Polypill treatments for cardiovascular diseasesRuth Webster, Anthony Rodgers
Journal of Hypertension|April 4, 2018
False reassurance about the consequences of withdrawing antihypertensive drug therapyAbdul Salam, Anthony Rodgers
Lancet (London, England)|November 11, 2008
Can we eliminate inequalities in coronary disease? AbsolutelyMartin Tobias, Anthony Rodgers
The New England Journal of Medicine|June 14, 2016
A Randomized Trial of Intensive versus Standard Blood-Pressure ControlAnthony Rodgers, Vlado Perkovic
Journal of Clinical Hypertension (Greenwich, Conn.)|March 26, 2019
Cardiovascular events with blood pressure lowering in patients with diabetes and systolic blood pressure below 140 mm HgAbdul Salam, Anthony Rodgers
Lancet (London, England)|October 16, 2023
The ESH guidelines and missed prevention opportunitiesRod Jackson, Anthony Rodgers
Pageof 36